RNAi-based therapeutics and tumor targeted delivery in cancer

G Kara, GA Calin, B Ozpolat - Advanced drug delivery reviews, 2022 - Elsevier
Over the past decade, non-coding RNA-based therapeutics have proven as a great potential
for the development of targeted therapies for cancer and other diseases. The discovery of …

Targeting miRNAs and other non-coding RNAs as a therapeutic approach: an update

E Bayraktar, R Bayraktar, H Oztatlici… - Non-coding RNA, 2023 - mdpi.com
Since the discovery of the first microRNAs (miRNAs, miRs), the understanding of miRNA
biology has expanded substantially. miRNAs are involved and described as master …

[HTML][HTML] The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment

H Zhang, L Fu - Acta Pharmaceutica Sinica B, 2021 - Elsevier
A major mitochondrial enzyme for protecting cells from acetaldehyde toxicity is aldehyde
dehydrogenase 2 (ALDH2). The correlation between ALDH2 dysfunction and …

The interaction between two worlds: microRNAs and toll-like receptors

R Bayraktar, MTS Bertilaccio, GA Calin - Frontiers in immunology, 2019 - frontiersin.org
MicroRNAs (miRNAs) are critical mediators of posttranscriptional regulation via their
targeting of the imperfect antisense complementary regions of coding and non-coding …

A pan-cancer-bioinformatic-based literature review of TRPM7 in cancers

H Liu, JP Dilger, J Lin - Pharmacology & Therapeutics, 2022 - Elsevier
TRPM7, a divalent cation-selective channel with kinase domains, has been widely reported
to potentially affect cancers. In this study, we conducted multiple bioinformatic analyses …

FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression

G Hu, Z Yan, C Zhang, M Cheng, Y Yan… - Journal of Experimental …, 2019 - Springer
Abstract Background Forkhead box M1 (FOXM1) is a proliferation-associated transcription
factor of the forkhead box proteins superfamily, which includes four isoforms FOXM1a, b, c …

The comprehensive landscape of miR-34a in cancer research

S Li, X Wei, J He, Q Cao, D Du, X Zhan, Y Zeng… - Cancer and Metastasis …, 2021 - Springer
Abstract MicroRNA-34 (miR-34) plays central roles in human diseases, especially cancers.
Inactivation of miR-34 is detected in cancer cell lines and tumor tissues versus normal …

The crosstalk between reactive oxygen species and noncoding RNAs: From cancer code to drug role

J Zuo, Z Zhang, M Li, Y Yang, B Zheng, P Wang… - Molecular Cancer, 2022 - Springer
Oxidative stress (OS), characterized by the excessive accumulation of reactive oxygen
species (ROS), is an emerging hallmark of cancer. Tumorigenesis and development driven …

Targeted miR-34a delivery with PD1 displayed bacterial outer membrane vesicles-coated zeolitic imidazolate framework nanoparticles for enhanced tumor therapy

C Cui, Q He, J Wang, J Kang, W Ma, Y Nian… - International Journal of …, 2023 - Elsevier
MicroRNA (miRNA) has been widely used as an effective gene drug for tumor therapy, but
its chemical instability limited its therapeutic application in vivo. In this research, we fabricate …

Control of translation elongation in health and disease

JRP Knight, G Garland, T Pöyry… - Disease models & …, 2020 - journals.biologists.com
Regulation of protein synthesis makes a major contribution to post-transcriptional control
pathways. During disease, or under stress, cells initiate processes to reprogramme protein …